市場調査レポート

商品コード

1786987

末梢動脈疾患市場、規模、シェア、動向、産業分析レポート：治療タイプ別、流通チャネル別、エンドユーザー別、地域別- 市場予測、2025年～2034年

Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034, and By Region - Market Forecast, 2025-2034

出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 631,805円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 780,465円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 929,125円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.66円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、末梢動脈疾患（PAD）市場規模は2034年までに105億3,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

末梢動脈疾患（PAD）市場は、主に下肢に影響を及ぼす末梢動脈のアテローム硬化性閉塞の診断、治療、管理に焦点を当てています。この疾患は血流の低下を招き、疼痛、組織損傷、重症の場合は四肢切断を引き起こします。糖尿病、高血圧、喫煙、肥満などの危険因子の有病率の増加は、対象人口を拡大し、効果的なPAD治療に対する需要を煽っています。血管画像や早期診断ツールの進歩により発見率が向上している一方、低侵襲治療へのシフトにより、従来の手術よりも血管内治療が好まれる傾向にあります。薬剤溶出ステント、バルーン血管形成術、アテレクトミー・システムなどの技術進歩は、患者の転帰と手技効率を向上させています。市場開拓はさらに、併用療法や疾患の重症度や患者の併存疾患に合わせた個別化治療アプローチの開発によって支えられています。

デジタルヘルスプラットフォームの血管治療への統合は、遠隔モニタリング、治療アドヒアランス、データ主導の介入を可能にしています。研究と臨床試験への強力な投資は、特に抗再狭窄デバイスと生体吸収性インプラントの技術革新を形成し続けています。ヘルスケアプロバイダー、医療技術企業、研究機関の戦略的提携は、先進的なPADソリューションの商業化を促進しています。さらに、認知度向上キャンペーンやスクリーニングの取り組みが早期の介入を促し、対応可能な市場を拡大しています。価値観に基づく治療と患者中心の治療モデルが重視されるようになったことで、費用対効果が高くアウトカム重視のPAD治療の重要性が高まっています。市場競争と技術革新は依然として続いており、末梢血管疾患管理におけるアンメットニーズへの対応に尽力する利害関係者には大きなビジネスチャンスがもたらされます。

末梢動脈疾患市場レポートハイライト

治療タイプ別では、ステント、血管形成術用バルーン、低侵襲手術用アテレクトミーデバイスの採用拡大がデバイス分野の旺盛な需要に寄与していることから、2024年の売上シェアはデバイス分野が～62%を占めました。

流通チャネル別では、血管形成術やバイパス手術などの複雑なPADインターベンションのための患者流入が多く、病院薬局の優位性に寄与しているため、病院薬局セグメントが2024年に最大の収益シェアを占めました。

アジア太平洋は、急速に拡大するヘルスケアシステム、可処分所得の増加、健康意識の高まりがPADスクリーニングと診断率の向上に寄与しているため、2025年から2034年にかけて大きく成長すると予想されます。

北米の末梢動脈疾患市場は、糖尿病、肥満、喫煙などの心血管危険因子の高い有病率により、2024年に最大の売上シェアを占めました。

世界の主要企業には、Amedisys, Inc.、B. Braun SE、Baxter、BD、CareCentrix, Inc.、Coram LLC.、Fresenius Kabi AG、ICU Medical, Inc.、JMS Co.Ltd.、Moog Inc.、Option Care Health, Inc.、PharMerica Corporation、Terumo Corporation。

主な調査結果
イントロダクション
- 末梢動脈疾患市場評価：地域、2020年～2034年
北米
- 北米：治療タイプ別、2020年～2034年
- 北米：流通チャネル別、2020年～2034年
- 北米：エンドユーザー別、2020年～2034年
- 米国
- カナダ
欧州
- 欧州：治療タイプ別、2020年～2034年
- 欧州：流通チャネル別、2020年～2034年
- 欧州：エンドユーザー別、2020年～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：治療タイプ別、2020年～2034年
- アジア太平洋：流通チャネル別、2020年～2034年
- アジア太平洋：エンドユーザー別、2020年～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：治療タイプ別、2020年～2034年
- 中東・アフリカ：流通チャネル別、2020年～2034年
- 中東・アフリカ：エンドユーザー別、2020年～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：治療タイプ別、2020年～2034年
- ラテンアメリカ：流通チャネル別、2020年～2034年
- ラテンアメリカ：エンドユーザー別、2020年～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第10章企業プロファイル

Abbott
AngioDynamics
B. Braun SE
Bayer AG
BD
Biotronik
Boston Scientific Corporation
Cardinal Health
Endologix LLC
iVascular
Johnson & Johnson
Koninklijke Philips N.V.
Medtronic
Terumo Corporation

図表

List of Tables:

Table 1 Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 2 Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 3 Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 4 North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 5 North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 6 North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 7 U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 8 U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 9 U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 10 Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 11 Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 12 Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 13 Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 14 Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 15 Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 16 UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 17 UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 18 UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 19 France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 20 France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 21 France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 22 Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 23 Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 24 Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 25 Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 26 Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 27 Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 28 Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 29 Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 30 Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 31 Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 32 Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 33 Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 34 Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 35 Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 36 Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 43 China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 44 China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 45 China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 46 India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 47 India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 48 India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 49 Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 50 Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 51 Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 52 Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 53 Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 54 Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 55 Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 56 Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 57 Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 58 South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 59 South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 60 South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 61 Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 62 Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 63 Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 73 UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 74 UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 75 UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 76 Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 77 Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 78 Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 79 South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 80 South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 81 South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 85 Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 86 Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 87 Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 88 Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 89 Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 90 Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 91 Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 92 Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 93 Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 94 Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 95 Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 96 Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Peripheral Artery Disease Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Treatment Type
Figure 7. Global Peripheral Artery Disease Market, by Treatment Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Distribution Channel
Figure 9. Global Peripheral Artery Disease Market, by Distribution Channel, 2024 & 2034 (USD Billion)
Figure 10. Market by End User
Figure 11. Global Peripheral Artery Disease Market, by End User, 2024 & 2034 (USD Billion)

Product Code: PM6022

The peripheral artery disease (PAD) market size is expected to reach USD 10.53 billion by 2034, according to a new study by Polaris Market Research. The report "Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034," gives a detailed insight into current market dynamics and provides analysis on future market growth.

The peripheral artery disease (PAD) market focuses on the diagnosis, treatment, and management of atherosclerotic blockages in the peripheral arteries, primarily affecting the lower extremities. This condition leads to reduced blood flow, causing pain, tissue damage, and in severe cases, limb amputation. The increasing prevalence of risk factors such as diabetes, hypertension, smoking, and obesity is expanding the target population and fueling demand for effective PAD therapies. Advancements in vascular imaging and early diagnostic tools are improving detection rates, while the shift toward minimally invasive procedures is driving preference for endovascular treatments over traditional surgery. Technological progress in drug-eluting stents, balloon angioplasty, and atherectomy systems is enhancing patient outcomes and procedural efficiency. Market growth is further supported by the development of combination therapies and personalized treatment approaches tailored to disease severity and patient comorbidities.

The integration of digital health platforms into vascular care is enabling remote monitoring, treatment adherence, and data-driven interventions. Strong investments in research and clinical trials continue to shape innovation, particularly in anti-restenosis devices and bioresorbable implants. Strategic collaborations among healthcare providers, medtech firms, and research institutions are fostering the commercialization of advanced PAD solutions. In addition, increasing awareness campaigns and screening initiatives are encouraging earlier intervention, thus expanding the addressable market. Growing emphasis on value-based care and patient-centric treatment models is reinforcing the importance of cost-effective and outcome-driven PAD therapies. The market remains competitive and innovation-driven, presenting substantial opportunities for stakeholders committed to addressing unmet needs in peripheral vascular disease management.

Peripheral Artery Disease Market Report Highlights

By treatment type, the device segment accounted for ~62% of the revenue share in 2024, due to the wider adoption of stents, angioplasty balloons, and atherectomy devices for minimally invasive procedures is contributing to strong demand in the device segment.

Based on distribution channel, the hospital pharmacy segment accounted for the largest revenue share in 2024 due to the high patient inflow for complex PAD interventions, such as angioplasty or bypass surgeries, contributes to the dominance of hospital pharmacies.

Asia Pacific is expected to grow significantly from 2025 to 2034 due to rapidly expanding healthcare systems, rising disposable income, and growing health awareness are contributing to improved PAD screening and diagnosis rates.

The North America peripheral artery disease market accounted for the largest revenue share in 2024 due to the high prevalence of cardiovascular risk factors, such as diabetes, obesity, and smoking, has increased the burden of peripheral artery disease across the region.

A few global key players include Amedisys, Inc.; B. Braun SE; Baxter; BD; CareCentrix, Inc.; Coram LLC.; Fresenius Kabi AG; ICU Medical, Inc.; JMS Co. Ltd.; Moog Inc.; Option Care Health, Inc.; PharMerica Corporation; and Terumo Corporation.

Polaris Market Research has segmented the peripheral artery disease market report on the basis of treatment type, distribution channel, end user, and region:

By Treatment Type Outlook (Revenue, USD Billion, 2020-2034)

Device

Balloon Catheters

Plaque Modification Devices

Stents

Atherectomy Devices

Guidewires and Sheaths

Other Devices

Drug Type

Lipid-lowering Drugs

Antiplatelet Drugs

Thrombolytic Agents

Triple-H Therapy

Other Drugs

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacy

Retail Pharmacy

Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospital

Specialty Clinics

Ambulatory Surgical Centers

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Peripheral Artery Disease Market Insights

4.1. Peripheral Artery Disease Market - Market Snapshot
4.2. Peripheral Artery Disease Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Diabetes and Hypertension
  - 4.2.1.2. Aging Global Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High treatment costs.
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Peripheral Artery Disease Market Trends
4.6. Value Chain Analysis

5. Global Peripheral Artery Disease Market, by Treatment Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
5.3. Device
- 5.3.1. Global Peripheral Artery Disease Market, by Device, by Region, 2020-2034 (USD Billion)
- 5.3.2. Balloon Catheters
  - 5.3.2.1. Global Peripheral Artery Disease Market, by Balloon Catheters, 2020-2034 (USD Billion)
- 5.3.3. Plaque Modification Devices
  - 5.3.3.1. Global Peripheral Artery Disease Market, by Plaque Modification Devices, by Region, 2020-2034 (USD Billion)
- 5.3.4. Stents
  - 5.3.4.1. Global Peripheral Artery Disease Market, by Stents, 2020-2034 (USD Billion)
- 5.3.5. Atherectomy Devices
  - 5.3.5.1. Global Peripheral Artery Disease Market, by Atherectomy Devices, by Region, 2020-2034 (USD Billion)
- 5.3.6. Guidewires and Sheaths
  - 5.3.6.1. Global Peripheral Artery Disease Market, by Guidewires and Sheaths, 2020-2034 (USD Billion)
- 5.3.7. Other Devices
  - 5.3.7.1. Global Peripheral Artery Disease Market, by Other Devices, by Region, 2020-2034 (USD Billion)
5.4. Drug Type
- 5.4.1. Global Peripheral Artery Disease Market, by Drug Type, by Region, 2020-2034 (USD Billion)
- 5.4.2. Lipid-lowering Drugs
  - 5.4.2.1. Global Peripheral Artery Disease Market, by Lipid-lowering Drugs, 2020-2034 (USD Billion)
- 5.4.3. Antiplatelet Drugs
  - 5.4.3.1. Global Peripheral Artery Disease Market, by Antiplatelet Drugs, by Region, 2020-2034 (USD Billion)
- 5.4.4. Thrombolytic Agents
  - 5.4.4.1. Global Peripheral Artery Disease Market, by Thrombolytic Agents, 2020-2034 (USD Billion)
- 5.4.5. Triple-H Therapy
  - 5.4.5.1. Global Peripheral Artery Disease Market, by Triple-H Therapy, by Region, 2020-2034 (USD Billion)
- 5.4.6. Other Drugs
  - 5.4.6.1. Global Peripheral Artery Disease Market, by Other Drugs, 2020-2034 (USD Billion)

6. Global Peripheral Artery Disease Market, by Distribution Channel

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
6.3. Hospital Pharmacy
- 6.3.1. Global Peripheral Artery Disease Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
6.4. Retail Pharmacy
- 6.4.1. Global Peripheral Artery Disease Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
6.5. Others
- 6.5.1. Global Peripheral Artery Disease Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Peripheral Artery Disease Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
7.3. Hospital
- 7.3.1. Global Peripheral Artery Disease Market, by Hospital, by Region, 2020-2034 (USD Billion)
7.4. Specialty Clinics
- 7.4.1. Global Peripheral Artery Disease Market, by Specialty Clinics, by Region, 2020-2034 (USD Billion)
7.5. Ambulatory Surgical Centers
- 7.5.1. Global Peripheral Artery Disease Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)

8. Global Peripheral Artery Disease Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Peripheral Artery Disease Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Peripheral Artery Disease Market - North America
- 8.3.1. North America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.3. North America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Peripheral Artery Disease Market - U.S.
  - 8.3.4.1. U.S.: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Peripheral Artery Disease Market - Canada
  - 8.3.5.1. Canada: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.4. Peripheral Artery Disease Market - Europe
- 8.4.1. Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.3. Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Peripheral Artery Disease Market - UK
  - 8.4.4.1. UK: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Peripheral Artery Disease Market - France
  - 8.4.5.1. France: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Peripheral Artery Disease Market - Germany
  - 8.4.6.1. Germany: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Peripheral Artery Disease Market - Italy
  - 8.4.7.1. Italy: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Peripheral Artery Disease Market - Spain
  - 8.4.8.1. Spain: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Peripheral Artery Disease Market - Netherlands
  - 8.4.9.1. Netherlands: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Peripheral Artery Disease Market - Russia
  - 8.4.10.1. Russia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Peripheral Artery Disease Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.5. Peripheral Artery Disease Market - Asia Pacific
- 8.5.1. Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Peripheral Artery Disease Market - China
  - 8.5.4.1. China: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Peripheral Artery Disease Market - India
  - 8.5.5.1. India: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Peripheral Artery Disease Market - Malaysia
  - 8.5.6.1. Malaysia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Peripheral Artery Disease Market - Japan
  - 8.5.7.1. Japan: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Peripheral Artery Disease Market - Indonesia
  - 8.5.8.1. Indonesia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Peripheral Artery Disease Market - South Korea
  - 8.5.9.1. South Korea: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Peripheral Artery Disease Market - Australia
  - 8.5.10.1. Australia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Peripheral Artery Disease Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.6. Peripheral Artery Disease Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Peripheral Artery Disease Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Peripheral Artery Disease Market - UAE
  - 8.6.5.1. UAE: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Peripheral Artery Disease Market - Israel
  - 8.6.6.1. Israel: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Peripheral Artery Disease Market - South Africa
  - 8.6.7.1. South Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Peripheral Artery Disease Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
8.7. Peripheral Artery Disease Market - Latin America
- 8.7.1. Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Peripheral Artery Disease Market - Mexico
  - 8.7.4.1. Mexico: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Peripheral Artery Disease Market - Brazil
  - 8.7.5.1. Brazil: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Peripheral Artery Disease Market - Argentina
  - 8.7.6.1. Argentina: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Peripheral Artery Disease Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Peripheral Artery Disease Market, by Treatment Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Peripheral Artery Disease Market, by Distribution Channel, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Peripheral Artery Disease Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AngioDynamics
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. B. Braun SE
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Bayer AG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. BD
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Biotronik
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Boston Scientific Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Cardinal Health
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Endologix LLC
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. iVascular
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Johnson & Johnson
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Koninklijke Philips N.V.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Medtronic
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Terumo Corporation
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development

末梢動脈疾患市場、規模、シェア、動向、産業分析レポート：治療タイプ別、流通チャネル別、エンドユーザー別、地域別- 市場予測、2025年～2034年

Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034, and By Region - Market Forecast, 2025-2034

末梢動脈疾患市場レポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の末梢動脈疾患市場の洞察

第5章世界の末梢動脈疾患市場：治療タイプ別

第6章世界の末梢動脈疾患市場：流通チャネル別

第7章世界の末梢動脈疾患市場：エンドユーザー別

第8章世界の末梢動脈疾患市場：地域

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

Peripheral Artery Disease Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Peripheral Artery Disease Market Insights

5. Global Peripheral Artery Disease Market, by Treatment Type

6. Global Peripheral Artery Disease Market, by Distribution Channel

7. Global Peripheral Artery Disease Market, by End User

8. Global Peripheral Artery Disease Market, by Geography

9. Competitive Landscape

10. Company Profiles

末梢動脈疾患市場、規模、シェア、動向、産業分析レポート：治療タイプ別、流通チャネル別、エンドユーザー別、地域別- 市場予測、2025年～2034年

Peripheral Artery Disease Market Size, Share, Trend, Industry Analysis Report By Treatment Type (Device, Drugs), By Distribution Channel, By End User, By Region - Market Forecast, 2025-2034, and By Region - Market Forecast, 2025-2034

末梢動脈疾患市場レポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の末梢動脈疾患市場の洞察

第5章 世界の末梢動脈疾患市場：治療タイプ別

第6章 世界の末梢動脈疾患市場：流通チャネル別

第7章 世界の末梢動脈疾患市場：エンドユーザー別

第8章 世界の末梢動脈疾患市場：地域

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

Peripheral Artery Disease Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Peripheral Artery Disease Market Insights

5. Global Peripheral Artery Disease Market, by Treatment Type

6. Global Peripheral Artery Disease Market, by Distribution Channel

7. Global Peripheral Artery Disease Market, by End User

8. Global Peripheral Artery Disease Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の末梢動脈疾患市場の洞察

第5章世界の末梢動脈疾患市場：治療タイプ別

第6章世界の末梢動脈疾患市場：流通チャネル別

第7章世界の末梢動脈疾患市場：エンドユーザー別

第8章世界の末梢動脈疾患市場：地域

第9章競合情勢

第10章企業プロファイル